ErbB receptors in the biology and pathology of the aerodigestive tract.
ErbB receptors in the biology and pathology of the aerodigestive tract.
复制标题
DOI:
10.1016/j.yexcr.2008.08.009
复制
发表时间:
2009-02-15
影响因子:
3.7
通讯作者:
Grandis JR
中科院分区:
文献类型:
--
作者:
Morgan S;Grandis JR
The most common sites of malignancies in the aerodigestive tract include the lung, head and neck and the esophagus. Esophageal adenocarcinomas (EA), esophageal squamous cell carcinomas (ESCC), and squamous cell carcinomas of the head and neck (SCCHN) are the primary focus of this review. Traditional treatment for aerodigestive tract cancers includes primary chemoradiotherapy (CRT) or surgical resection followed by radiation (or CRT). Recent developments in treatment have focused increasingly on molecular targeting strategies including cetuximab (a monoclonal antibody against epidermal growth factor receptor (EGFR)). Cetuximab was FDA approved in 2006 for treatment of SCCHN, underscoring the importance of understanding the biology of these malignancies. EGFR is a member of the ErbB family of growth factor receptor tyrosine kinases. The major pathways activated by ErbB receptors include Ras/Raf/MAPK; PI3K/AKT; PLCγ and STATs, all of which lead to the transcription of target genes that may contribute to aerodigestive tumor progression. This review explores the expression of ErbB receptors in EA, ESCC and SCCHN and the signaling pathways of EGFR in SCCHN.
登录
查看更多内容
DOI:
10.1002/hed.20574
发表时间:
2007-07-01
影响因子:
2.9
作者:
Cavalot, Andrea;Martone, Tiziana;Cortesina, Giorgio
通讯作者:
Cortesina, Giorgio
影响因子:
158.5
作者:
Bonner, JA;Harari, PM;Ang, KK
通讯作者:
Ang, KK
影响因子:
11.5
作者:
Erjala, Kaisa;Sundvall, Maria;Elenius, Klaus
通讯作者:
Elenius, Klaus
影响因子:
7.3
作者:
Bei, R;Budillon, A;Muraro, R
通讯作者:
Muraro, R
影响因子:
56.9
作者:
Engelman, Jeffrey A.;Zejnullahu, Kreshnik;Janne, Pasi A.
通讯作者:
Janne, Pasi A.